Pro Share Advisors LLC Aerie Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$4.95 - $9.16 $64,082 - $118,585	-12,946 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$5.64 - $9.8 $16,756 - $29,115	-2,971 Reduced 18.67%	12,946 $119,000
Q4 2021 Feb 08, 2022	BUY	$7.02 - $13.33 $2,808 - $5,332	400 Added 2.58%	15,917 $112,000
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $44,034 - $64,690	-3,890 Reduced 20.04%	15,517 $177,000
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $47,177 - $59,034	3,112 Added 19.1%	19,407 $311,000

Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $12,345 - $19,666	941 Added 6.13%	16,295 $291,000
Q4 2020 Feb 09, 2021	BUY	$9.12 - $14.49 $30,652 - $48,700	3,361 Added 28.02%	15,354 $207,000
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $4,382 - $6,058	-419 Reduced 3.38%	11,993 $141,000
Q2 2020 Aug 03, 2020	BUY	$12.0 - $16.13 $148,944 - $200,205	12,412 New	12,412 $183,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $186,349 - $401,659	-15,739 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$17.72 - $25.1 $26,544 - $37,599	-1,498 Reduced 8.69%	15,739 $380,000
Q3 2019 Nov 12, 2019	BUY	$18.41 - $28.0 $1,215 - $1,848	66 Added 0.38%	17,237 $331,000
Q2 2019 Aug 13, 2019	SELL	$28.97 - $48.21 $61,937 - $103,072	-2,138 Reduced 11.07%	17,171 $507,000
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $5,593 - $7,584	154 Added 0.8%	19,309 $917,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $120,120 - $218,545	-3,640 Reduced 15.97%	19,155 $691,000
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $84,954 - $111,810	1,513 Added 7.11%	22,795 $1.4 Million
Q2 2018 Aug 13, 2018	SELL	$47.85 - $70.45 $29,906 - $44,031	-625 Reduced 2.85%	21,282 $1.44 Million
Q1 2018 May 14, 2018	SELL	$51.15 - $61.0 $142,503 - $169,946	-2,786 Reduced 11.28%	21,907 $1.19 Million
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $100,174 - $128,246	1,970 Added 8.67%	24,693 $1.48 Million
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $100,164 - $123,866	2,061 Added 9.97%	22,723 $1.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	20,662	20,662 $1.09 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account